ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 279 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $2,634,751 | -60.1% | 142,496 | -55.0% | 0.05% | -57.5% |
| Q3 2023 | $6,597,006 | +40.9% | 316,555 | +61.9% | 0.13% | +38.0% |
| Q2 2023 | $4,682,153 | +115.0% | 195,497 | +69.0% | 0.09% | +109.1% |
| Q1 2023 | $2,177,455 | +94.2% | 115,699 | +45.4% | 0.04% | -12.0% |
| Q2 2022 | $1,121,000 | +124.6% | 79,579 | +272.5% | 0.05% | +78.6% |
| Q4 2021 | $499,000 | -35.4% | 21,366 | -28.7% | 0.03% | -75.2% |
| Q1 2021 | $773,000 | +257.9% | 29,975 | +643.1% | 0.11% | +222.9% |
| Q4 2020 | $216,000 | -71.4% | 4,034 | -77.9% | 0.04% | -78.5% |
| Q3 2020 | $754,000 | – | 18,287 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 647,833 | $26,723,000 | 11.32% |
| GREAT POINT PARTNERS LLC | 1,921,563 | $79,264,000 | 7.13% |
| Baker Brothers Advisors | 41,904,586 | $1,728,564,000 | 6.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 486,000 | $20,048,000 | 6.47% |
| Palo Alto Investors LP | 1,832,300 | $75,582,000 | 4.15% |
| Birchview Capital, LP | 204,000 | $8,416,000 | 2.81% |
| SECTORAL ASSET MANAGEMENT INC | 556,514 | $22,956,000 | 1.97% |
| Rock Springs Capital Management LP | 1,573,200 | $64,895,000 | 1.65% |
| Riggs Asset Managment Co. Inc. | 17,470 | $2,025,000 | 0.85% |
| PFM Health Sciences, LP | 421,087 | $17,370,000 | 0.80% |